Does TOFACITINIB Cause Thrombosis? 1,143 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,143 reports of Thrombosis have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.7% of all adverse event reports for TOFACITINIB.
1,143
Reports of Thrombosis with TOFACITINIB
0.7%
of all TOFACITINIB reports
86
Deaths
420
Hospitalizations
How Dangerous Is Thrombosis From TOFACITINIB?
Of the 1,143 reports, 86 (7.5%) resulted in death, 420 (36.7%) required hospitalization, and 126 (11.0%) were considered life-threatening.
Is Thrombosis Listed in the Official Label?
Yes, Thrombosis is listed as a known adverse reaction in the official FDA drug label for TOFACITINIB.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Thrombosis?
LENALIDOMIDE (6,433)
APIXABAN (5,298)
RIVAROXABAN (3,220)
ADALIMUMAB (2,334)
POMALIDOMIDE (1,158)
RITUXIMAB (1,083)
ETANERCEPT (1,051)
METHOTREXATE (981)
PREDNISONE (963)
WARFARIN (925)
Which TOFACITINIB Alternatives Have Lower Thrombosis Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN